No information
No information is present at this moment.
No information is present at this moment.
| Calcium deficiency |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
In the case of mild hypercalciuria (exceeding 0.12 - 0.015 mmol or 4.8-0.6 mg / kg / 24 hours in children), in renal insufficiency and in nephrolithiasis carefully control the excretion of calcium and phosphate in the urine; in the case of increased excretion, the dosage must be reduced or the calcium therapy discontinued [SmPC].
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Calcium | ||
|---|---|---|
| A12AA06 | ||
| Calcium, combinations with vitamin D and/or other drugs | ||
|---|---|---|
| A12AX | ||
| CALCIUM | ||
|---|---|---|
| A12AA06 | ||
| Calcium, combinations with vitamin D and/or other drugs | ||
|---|---|---|
| A12AX | ||